Life Seal Vascular offers the CYGNUM Aneurysm Sac Management Device, a rapid, imaging‑independent tool that seals type II endoleaks during EVAR procedures.
Funding
Funding not disclosed
Founders
Product
Problem
Type II endoleaks after endovascular aneurysm repair (EVAR) allow blood to re‑enter the aneurysm sac, leading to sac enlargement, rupture, and a five‑fold increase in aneurysm‑related mortality. Approximately one‑third of EVAR patients require repeat interventions to address these leaks.
Solution
Life Seal Vascular’s CYGNUM Aneurysm Sac Management Device provides a rapid, imaging‑independent method to occlude type II endoleaks. The device can be deployed in about five minutes through any standard EVAR platform and conforms to a wide range of aortic anatomies using a limited set of sizes. By sealing the aneurysm sac directly, it reduces the need for repeat procedures, lowers the risk of rupture and mortality, and offers a cost‑efficient alternative to prolonged imaging surveillance or complex secondary interventions. The technology is also adaptable for use in abdominal, iliac, venous, and thoracic applications, extending its utility beyond the initial indication.
Target Audience
Primary customers are vascular surgeons and interventional radiologists who perform EVAR procedures and manage post‑EVAR complications, as well as hospitals and specialty clinics seeking to minimize reintervention rates.
Features
- Stand‑alone occlusion device compatible with all commercially available EVAR systems
- Quick deployment workflow (~5 minutes) without the need for intra‑operative imaging guidance
- Predictable sizing and fit across diverse anatomies using a minimal SKU portfolio
- Platform design enabling use in abdominal, iliac, venous, and thoracic vascular territories
- Cost‑efficient solution that reduces reliance on repeat imaging and secondary interventions